Why did the U.S. FDA decline to review the new mRNA influenza vaccine?
On February 3, 2026, the US FDA issued a ‘refusal to file’ (RTF) letter to Moderna Inc. regarding their new mRNA vaccine developed against influenza. This decision generated considerable controversy worldwide, particularly given the current direction of vaccination policy in the United States towards a more conservative approach. However, that does not necessarily mean that…
Read More “Why did the U.S. FDA decline to review the new mRNA influenza vaccine?” »